Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

United Therapeutics (UTHR) Tax Rate (2016 - 2025)

Historic Tax Rate for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to 22.67%.

  • United Therapeutics' Tax Rate rose 22100.0% to 22.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 23.69%, marking a year-over-year increase of 9400.0%. This contributed to the annual value of 22.35% for FY2024, which is 3700.0% down from last year.
  • Per United Therapeutics' latest filing, its Tax Rate stood at 22.67% for Q3 2025, which was up 22100.0% from 24.22% recorded in Q2 2025.
  • Over the past 5 years, United Therapeutics' Tax Rate peaked at 26.51% during Q4 2023, and registered a low of 12.92% during Q1 2021.
  • Its 5-year average for Tax Rate is 22.06%, with a median of 22.67% in 2023.
  • As far as peak fluctuations go, United Therapeutics' Tax Rate tumbled by -68300bps in 2021, and later surged by 93600bps in 2022.
  • Quarter analysis of 5 years shows United Therapeutics' Tax Rate stood at 20.14% in 2021, then grew by 30bps to 26.12% in 2022, then grew by 1bps to 26.51% in 2023, then fell by -9bps to 24.01% in 2024, then fell by -6bps to 22.67% in 2025.
  • Its last three reported values are 22.67% in Q3 2025, 24.22% for Q2 2025, and 23.92% during Q1 2025.